Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.14M Buy
2,376
+2
+0.1% +$1.02K 0.08% 119
2025
Q4
$1.33M Buy
2,374
+8
+0.3% +$4.54K 0.09% 105
2025
Q3
$1.22M Sell
2,366
-55
-2% -$24K 0.08% 112
2025
Q2
$760K Buy
2,421
+35
+1% +$10.5K 0.06% 166
2025
Q1
$727K Buy
2,386
+9
+0.4% +$3.03K 0.06% 157
2024
Q4
$790K Sell
2,377
-3
-0.1% -$1.02K 0.07% 120
2024
Q3
$794K Buy
2,380
+23
+1% +$8.74K 0.07% 122
2024
Q2
$971K Hold
2,357
0.1% 87
2024
Q1
$953K Buy
2,357
+3
+0.1% +$1.05K 0.1% 87
2023
Q4
$722K Hold
2,354
0.08% 98
2023
Q3
$570K Hold
2,354
0.07% 112
2023
Q2
$565K Hold
2,354
0.07% 113
2023
Q1
$443K Hold
2,354
0.06% 133
2022
Q4
$500K Hold
2,354
0.08% 96
2022
Q3
$370K Hold
2,354
0.07% 107
2022
Q2
$352K Hold
2,354
0.06% 121
2022
Q1
$385K Sell
2,354
-366
-13% -$60.3K 0.07% 122
2021
Q4
$592K Sell
2,720
-38
-1% -$7.96K 0.11% 81
2021
Q3
$522K Hold
2,758
0.12% 84
2021
Q2
$487K Hold
2,758
0.12% 87
2021
Q1
$452K Hold
2,758
0.13% 83
2020
Q4
$384K Hold
2,758
0.13% 85
2020
Q3
$308K Sell
2,758
-17
-0.6% -$1.97K 0.13% 91
2020
Q2
$258K Sell
2,775
-1
-0% -$85 0.12% 101
2020
Q1
$204K Buy
2,776
+33
+1% +$2.87K 0.13% 91
2019
Q4
$231K Buy
2,743
+7
+0.3% +$542 0.15% 87
2019
Q3
$230K Buy
+2,736
New +$207K 0.16% 81

Other funds holding MEDP

PDS Planning's MEDP Position: Q1 2026 in Review

PDS Planning increased its Medpace (MEDP) stake by 0.08% in Q1 2026, buying an estimated $1.02K and bringing the position to 2,376 shares worth $1.14M. The position accounts for 0.08% of the portfolio, ranked #119.

PDS Planning first reported a position in MEDP in Q3 2019 and has held it in 27 quarters since. The position peaked at $1.33M in Q4 2025. 729 funds tracked by Wall St. Rank hold MEDP as of Q1 2026.

  • PDS Planning held 2,376 shares of Medpace worth $1.14M as of Q1 2026.
  • PDS Planning bought 2 Medpace shares in Q1 2026, an estimated $1.02K.
  • Medpace made up 0.08% of PDS Planning's portfolio in Q1 2026, its #119 holding.
  • PDS Planning first reported a position in Medpace in Q3 2019 and has held it in 27 quarters since.
  • PDS Planning's Medpace position peaked at $1.33M in Q4 2025.
  • 729 funds tracked by Wall St. Rank held Medpace as of Q1 2026.

Based on PDS Planning's 13F filing for Q1 2026, filed 22 Apr 2026.